Disclosed herein is a method for measuring the contractility of intestinal tissue upon treatment with GLP-2 or a GLP-2 ligand. Also disclosed is an assay which directly measures the activity of GLP-2 or GLP-2 ligands ex vivo and permits the screening of putative GLP-2 ligands in native tissue.

 
Web www.patentalert.com

< Process for solubilizing glucagon-like peptide 1 compounds

> Method of treating a subject suffering stroke comprising administering Glucagon-like peptide-1 analogs

> Gastrointestinal methods and apparatus for use in treating disorders
~ 00504